List of insiders holdings for Artiva Biotherapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2024-09-03 16:18:05 | 9,853,302 0 | 9,853,302 | Form 13D |
GC Corp. GC Cell Corp 10% Owner | 2024-07-29 16:15:58 | 4,567,412 0 | 4,567,412 | Form 13D |
5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 2024-08-01 16:17:22 | 2,353,304 0 | 2,353,304 | Form 13G |
Huh Yong-Jun Director | 2024-07-22 20:22:03 | 0 1,810,945 | 1,810,945 | Form 4 |
venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner | 2024-11-14 16:56:18 | 1,519,971 0 | 1,519,971 | Form 13G |
Aslan Fred President and CEO | 2024-07-22 20:18:50 | 572,716 0 | 572,716 | Form 4 |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 2024-07-22 20:28:17 | 243,127 0 | 243,127 | Form 4 |
Bush Jennifer COO, CLO, Secy, Compliance Off | 2024-09-13 16:15:10 | 72,799 0 | 72,799 | Form 4 |
Krishnamohan Neha Chief Financial Officer | 2024-09-13 16:15:13 | 50,000 0 | 50,000 | Form 4 |
MOORE ALISON Director | 2024-10-22 20:18:32 | 27,500 0 | 27,500 | Form 4 |
Miralles Gines Diego Director | 2024-07-18 20:06:41 | 25,990 0 | 25,990 | Form 3 |
Horan Christopher Chief Tech Operations Officer | 2024-09-13 16:15:17 | 25,000 0 | 25,000 | Form 4 |
Graef Thorsten Chief Medical Officer | 2024-09-13 16:15:20 | 20,000 0 | 20,000 | Form 4 |
HOUGEN ELIZABETH L Director | 2024-07-18 20:04:01 | 17,098 0 | 17,098 | Form 3 |
Bessen Laura Director | 2024-07-18 20:02:02 | 17,098 0 | 17,098 | Form 3 |
Raymon Heather SVP, Research and Development | 2024-09-13 16:15:24 | 10,000 0 | 10,000 | Form 4 |
Stoppel Laura Director | 2024-07-18 20:05:15 | 0 0 | 0 | Form 3 |
DANIELS BRIAN Director | 2024-07-18 20:03:48 | 0 0 | 0 | Form 3 |